Log in to save to my catalogue

Lomitapide, a cholesterol-lowering drug, is an anticancer agent that induces autophagic cell death v...

Lomitapide, a cholesterol-lowering drug, is an anticancer agent that induces autophagic cell death v...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9054af44fd03415eaeb6df3aad49c4bd

Lomitapide, a cholesterol-lowering drug, is an anticancer agent that induces autophagic cell death via inhibiting mTOR

About this item

Full title

Lomitapide, a cholesterol-lowering drug, is an anticancer agent that induces autophagic cell death via inhibiting mTOR

Publisher

London: Nature Publishing Group UK

Journal title

Cell death & disease, 2022-07, Vol.13 (7), p.603-603, Article 603

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Autophagy is a biological process that maintains cellular homeostasis and regulates the internal cellular environment. Hyperactivating autophagy to trigger cell death has been a suggested therapeutic strategy for cancer treatment. Mechanistic target of rapamycin (mTOR) is a crucial protein kinase that regulates autophagy; therefore, using a structu...

Alternative Titles

Full title

Lomitapide, a cholesterol-lowering drug, is an anticancer agent that induces autophagic cell death via inhibiting mTOR

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_9054af44fd03415eaeb6df3aad49c4bd

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9054af44fd03415eaeb6df3aad49c4bd

Other Identifiers

ISSN

2041-4889

E-ISSN

2041-4889

DOI

10.1038/s41419-022-05039-6

How to access this item